Vaccines for melanoma - Design strategies and clinical results

被引：12

作者：

Bystryn, JC ^{[1
]}

机构：

[1] Ronald O Perelman Dept Dermatol, New York, NY USA

来源：

DERMATOLOGIC CLINICS | 1998年 / 16卷 / 02期

关键词：

D O I：

10.1016/S0733-8635(05)70009-7

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Melanoma vaccines represent a novel and potentially effective method of slowing the progression of melanoma. This article discusses the importance in the design of vaccines for melanoma, the relative advantages and disadvantages of this approach, and summarizes the results of the most important clinical trials conducted to date with this vaccine.

引用

页码：269 / +

页数：8

共 23 条

[1]

APPLEBAUM J, 1998, J NATL CANC I

[2]

BERD D, 1993, ANN NY ACAD SCI, V690, P147

[3]

BERTHIERVERGNES O, 1994, CANCER RES, V54, P2433

[4]

BYSTRYN JC, 1992, CANCER-AM CANCER SOC, V69, P1157, DOI 10.1002/cncr.2820690516

[5]

BYSTRYN JC, 1993, ANN NY ACAD SCI, V690, P190

[6]

BYSTRYN JC, 1978, J IMMUNOL, V120, P96

[7]

BYSTRYN JC, 1995, BIOL THERAPY CANC, P668

[8]

COULIE P, 1993, ANN NY ACAD SCI, V690, P113

[9]

FERRONE S, 1993, ANN NY ACAD SCI, V690, P214

[10] HUMAN GENE MAGE-3 CODES FOR AN ANTIGEN RECOGNIZED ON A MELANOMA BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES [J].

GAUGLER, B ;

VANDENEYNDE, B ;

VANDERBRUGGEN, P ;

ROMERO, P ;

GAFORIO, JJ ;

DEPLAEN, E ;

LETHE, B ;

BRASSEUR, F ;

BOON, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :921-930

← 1 2 3 →